Firms

Chrysalis Ventures

Chrysalis Ventures

Louisville, Kentucky, United States

Chrysalis Ventures is the Louisville, Kentucky private-market investment firm whose current official site uses the Chrysalis Capital brand. The SEC identifies its legal adviser as Chrysalis Capital, LLC DBA Chrysalis Ventures, LLC (CRD161827; exempt-reporting adviser file802-75702), establishing the brand and legal-identity bridge. Founded in1993, it invests in technology-enabled healthcare, education, workforce and business-services companies. Its published strategy includes predictive analytics and technology applied to established businesses, organic growth and acquisitions. The firm reports investing in more than70 companies and publishes four current investment professionals. Current biographies name BehaVR, Confluent Health, AlayaCare, meQuilibrium and other healthcare/data businesses. It was named an institutional participant in the December2022 BehaVR/OxfordVR USD13M SeriesB; company financing is maintained separately. Official regulatory and limited-partner records identify several historical fund vehicles, but their holding valuations, GAV and limited-partner commitments are not fund closing amounts. Secondary claims of USD175M and USD163M fund closes lack exact primary closing confirmation in this audit; no target or AUM is assigned as cash. The unrelated existing Chrysalis Investments and The Chrysalis Capital records are preserved. Founding year1993 is source-qualified; exact founding day is unpublished.

Founded
1993
Type
Venture capital

Funds4

  • Chrysalis Ventures (Healthcare) III LP—

    Official CalPERS limited-partner report names exact historical vehicle. LP fees and carrying values are not fund closing amounts. Final corpus, closing date and paid-in total remain unverified; all amount/date fields NULL. These are legal funds, not additional manager or duplicate issuer checks.

  • Chrysalis Ventures (Ohio) III, LP—

    Manager own SEC FormADV names exact managed private fund. GAV, investors and minimum commitments are not fund closed cash. Final corpus, closing date and paid-in total remain unverified; all amount/date fields NULL. These are legal funds, not additional manager or duplicate issuer checks.

  • Chrysalis Ventures II, L.P.—

    Issuer SEC shareholder agreement expressly names legal fund and Chrysalis Partners II LLC GP. No close amount/date established. Final corpus, closing date and paid-in total remain unverified; all amount/date fields NULL. These are legal funds, not additional manager or duplicate issuer checks.

  • Chrysalis Ventures III, L.P.—

    Official limited-partner filing confirms actual historical fund. Its holding valuation is not the fund corpus or new close. Final corpus, closing date and paid-in total remain unverified; all amount/date fields NULL. These are legal funds, not additional manager or duplicate issuer checks.

Team

Operations and support

Charlie CrawfordCharlie CrawfordVice President
David Jones Jr.David Jones Jr.Chairman & Managing Partner
Irv BaileyIrv BaileyManaging Director

Co-investing

Investments